Opaleye Management Inc. Catalyst Biosciences, Inc. Transaction History

Opaleye Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $5.13 Million - $6.66 Million	-1,250,000 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$4.93 - $7.15 $5.43 Million - $7.87 Million	1,101,200 Added 740.05%	1,250,000 $6.3 Million
Q4 2020 Feb 12, 2021	BUY	$4.55 - $7.29 $677,040 - $1.08 Million	148,800 New	148,800 $939,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.